Philippine Council for Health Research and Development(PCHRD)

August 10, 2022 Dear Ms. Maricris Cadaba, Thank you for your request dated August 10, 2022, under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch on the following researches: Efficacy of Sambong Tablet in Filipino Patients with Distal 3rd Ureterolithiasis Blumea balsamifera L. (Sambong) for the treatment of Urinary Tract Stone: A Randomized placebo controlled study Phase III Clinical Trial NIRPROMP. Blumea balsamifera L. (Sambong) for the treatment of Urinary Tract Stones: A randomized placebo controlled study Phase III Clinical Trial The Philippine Council for Health Research and Development (PCHRD), one of the sectoral councils of the Department of Science and Technology (DOST), is mandated to: (1) formulate policies, plans, programs, project, and strategies for health S&T development; (2) program and allocate government and external funds for research and development (R&D); (3) monitor R&D projects; and (4) generate external funds. While our aim is to provide information whenever possible, we regret that our office does not have the information you have requested. However, we referred your request to the University of the Philippines (UP) Manila to assist you with your concern. You may also directly coordinate with the following institutions at: UP Manila College of Medicine Email address: [email protected] Telephone number: (632) 8536-1392 UP Manila College of Pharmacology Telephone number: (632) 8526-4170 University of the East Ramon Magsaysay Memorial Medical Center, Inc. Telephone number: (632) 8715-0861 For related studies, you may also visit HERDIN PLUS at http://herdin.ph. Should you have further queries, kindly contact us using the reply function on the eFOI portal at https://www.foi.gov.ph/requests/aglzfmVmb2ktcGhyHwsSB0NvbnRlbnQiElBDSFJELTcxMzE0ODUxNDI0NQw, with ticket number #PCHRD-713148514245. Respectfully yours, Alec Gonzales DOST-PCHRD FOI Receiving Officer